News Agency
The Times

Brii Biosciences Provides Update on Strategic Clinical Development Progress

  • Written by PR Newswire
Brii Biosciences Provides Update on Strategic Clinical Development Progress

Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023

Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment

U.S. FDA lifted clinical hold on BRII-732 allowing the Company to reinitiate a...

Read more: Brii Biosciences Provides Update on Strategic Clinical Development Progress

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion